Changjiang Runfa Medicine Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Changjiang Runfa Medicine Co Ltd with three other
companies in this sector in CHINA :
Tianjin Chase Sun Pharmaceutical Company Limited
sales of 5.00 billion Chinese Renmimbi [US$771.45 million]
of which 54%
Shandong Xinhua Pharmaceutical Company Limited
(5.61 billion Chinese Renmimbi [US$864.45 million]
of which 57%
was Preparations), and
Shenzhen Hepalink Pharmaceutical Group Co Ltd
(4.62 billion Chinese Renmimbi [US$713.12 million]
of which 100%
was Pharmaceutical Manufacturing).
During the year ended December of 2019, sales at
Changjiang Runfa Medicine Co Ltd were 5.07 billion Chinese Renmimbi (US$782.24 million).
increase of 8.5%
versus 2018, when the company's sales were 4.67 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Changjiang Runfa Medicine Co Ltd.
Sales of Elevator Parts Manufacturing saw an increase
10.8% in 2019, from
1.29 billion Chinese Renmimbi to 1.43 billion Chinese Renmimbi.